Print

Protalix Biotherapeutics, Inc. (PLX) to Present at the Oppenheimer 14th Annual Israeli Conference  
5/8/2013 9:29:09 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CARMIEL, Israel, May 8, 2013 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), today announced that Dr. David Aviezer, the Company's President and Chief Executive Officer, will present at the Oppenheimer 14th Annual Israeli Conference on Sunday, May 12, 2013 at 3:35PM IDT. The conference is being held at the David Intercontinental Hotel in Tel Aviv, Israel.

Help employers find you! Check out all the jobs and post your resume.

//-->